Tech
Check out the latest TeleHealth news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts.
Health & Biotech
InteliCare just burst onto the multi-billion dollar wearables scene, synching with 60 leading global brands
Health & Biotech
Locked and loaded: InteliCare poised for growth with giant Optus, Bethanie deal
Health & Biotech
InteliCare doubles sales revenue as aged care AI delivers record customer growth
Health & Biotech
Intelicare announces another record quarter with a 55% rise in sales
Stockhead TV
Health Tech: New innovations geared toward personalised care post pandemic
Tech
Intelicare announces successful $2.99 million raise and new cornerstone investor
Health & Biotech
InteliCare lands MercyCare contract to provide AI-based smart tech for independent living
Health & Biotech
InteliCare reports record quarter with 120% growth in B2B partnerships
Health & Biotech
InteliCare secures major contract with St John of God Health Care
Stockhead TV
Digital Health: Key trends, new growth areas and emerging players
Health & Biotech
InteliCare targeting expansion as quarterly sales revenue rises 69%
Health & Biotech
Intelicare flags major traction from recent marketing drive as brand awareness rises sharply
Health & Biotech
HeraMED signs paid pilot with Obstetrix Medical Group, providers of care and diagnostics to 1 in 4 babies born in US
Health & Biotech
InteliCare flags booming growth as customer receipts double
Health & Biotech
InteliCare secures $2.5m to fund commercialisation strategy
Health & Biotech
Here’s why the COVID-induced telehealth boom is only just beginning
Health & Biotech
HeraMED secures landmark commercial agreement with Joondalup Health Campus
Health & Biotech
InteliCare launches first integrated consumer campaign targeting Australia’s west coast
News
ASX Small Cap Lunch Wrap: Health tech companies lead the way; oil royalties and media firms lag
Health & Biotech
Cannabis, medtech, telehealth – could any of these health microcaps be the next multi-bagger?
News
Closing Bell: Today’s biggest small cap movers on the ASX
Health & Biotech
Oneview Healthcare shares rise nearly 90pc following a Samsung distribution agreement
Health & Biotech
Why HeraMED’s HeraBEAT device could replace CTG machines in emerging economies
News
IPO Watch: Two gold explorers lead a pack of ASX debuts in January
Health & Biotech
Mayo Clinic approves clinical study of HeraMED’s HeraBEAT device
Health & Biotech
HeraMED taps into US employee benefit industry with Teleperinatal pilot
Aftermarket
Unicorns Podcast: ‘We are leading the telehealth revolution’ – Coviu CEO Dr Silvia Pfeiffer
Health & Biotech
Telehealth in 2021: What will change and will a COVID-19 vaccine stop the sector’s growth?
Health & Biotech
Unicorns Podcast: ‘The health tech revolution is upon us,’ says 1st Group’s Klaus Bartosch
Health & Biotech
HeraMED taps into US healthcare market with eCare21 partnership
IPO Watch
IPO Watch: Doctor Care Anywhere set to join the ASX telehealth ranks next month
Stockhead TV
Health tech plays are seeing tectonic shifts in customer growth
Health & Biotech
ASX asthma stocks: Global Health becomes the latest contender
News
10 at 10: These ASX stocks have found a way to make it this morning
Health & Biotech
InteliCare enters B2C aged care remote monitoring market
Health & Biotech
Successful clinical study for HeraBEAT device showcases its telehealth application
Tech
The ASX mental health stocks set to benefit from increased government spending
Health & Biotech
MGC Pharma launches CannEpil App for patients
Health & Biotech
InteliCare gets new distribution network with capital-light deal
Health & Biotech
Here’s what the ASX health sector must do to rival the tech sector
Health & Biotech
HeraMED breaks into US healthcare market with eCare21 partnership
News
Trust, innovation key to winning consumers as COVID-19 scars remain
Health & Biotech
Here’s what the telehealth industry wants from ScoMo to maintain momentum
Health & Biotech
StockDoc Podcast: Blood pressure monitoring tech hasn’t changed in a 100 years, CardieX is set on changing that
News
Short & Caught: The ASX stocks investors are shorting right now
Health & Biotech
HealthEngine to pay $2.9m for selling user data, changing reviews
Stockhead TV
StockTalk: How are ASX medtechs responding to skyrocketing healthcare spending?
Load More
